INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-2192289495-caner-patient-family-support-care]( "Rethinking Trial Access Through Trust-Driven Design And Local Collaboration")
Rethinking Trial Access Through Trust-Driven Design And Local CollaborationLocally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.
-
![GettyImages-2170642314-year 2025]( "What Does 2025 Hold For Pharma?")
What Does 2025 Hold For Pharma?Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.
-
![The Pharmacy Advantage]( "The Pharmacy Advantage In Direct-To-Patient Clinical Supply")
The Pharmacy Advantage In Direct-To-Patient Clinical SupplyUnderstand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.
-
![GettyImages-1477214805-cancer-cell-targeted]( "Challenges That Derail Bladder Cancer Trials And How To Anticipate Them Earlier")
Challenges That Derail Bladder Cancer Trials And How To Anticipate Them EarlierFrom the rapid evolution of standard-of-care benchmarks to the logistical strain of procedure-heavy urology workflows, the path to a successful endpoint is filled with operational friction.
-
How To Streamline The Complexity Of Clinical Trials1/30/2026
Streamlining intricate end-to-end processes ensures that data moves with speed and security, converting the current landscape of logistical bottlenecks into a transparent, high-efficiency engine.
-
Eligibility Criteria For Successful Retinal Study Delivery1/14/2026
Clear eligibility criteria drive retinal trial success. Explore how strategic design improves recruitment, safeguards data integrity, and meets compliance for studies on complex ocular conditions.
-
Meet Recruitment Goals Faster With Technology-Driven Patient Enrollment Solutions2/19/2026
Eliminate recruitment bottlenecks and reduce screen failures by integrating digital targeting, EMR intelligence, and real-time transparency into your clinical enrollment strategy.
-
Breaking Barriers In Drug Development: Time, Trust And Putting Patients First1/16/2025
Unpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.
-
Rescue Studies: Get Patient Recruitment Back On Track9/22/2025
What is a rescue study, and how can direct-to-patient digital recruitment be employed to rapidly boost recruitment and enrollment?
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Medicine-pills-tablets-GettyImages-545993684]( "Human Abuse Potential")
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "Supporting Sites And Patients With People-First Solutions")
Discover how Scout supports patient retention with people-first solutions for reimbursement and travel at no cost to sites.
-
![GettyImages-1181024482 payment]( "Site And Patient Payments")
With integrations at the heart of our efficiency model, Block Clinical automates payments in three areas: Site Payments, Patient Payments, and Supplier Payments.
-
![Cloud computing digita-GettyImages-2161057424]( "Unify Workflows And Accelerate Execution From Protocol To Submission")
Explore a platform that benefits the entire global clinical trial ecosystem by reducing complexity and operational costs while maintaining the highest standards of data security and subject privacy.
-
![GettyImages-956015576 knee altasciences_edited]( "Selecting The Right Pain Model For Early Phase Analgesic Trials")
Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
